Globe Life Inc. (NYSE:GL – Get Free Report) CFO Thomas Peter Kalmbach sold 7,936 shares of Globe Life stock in a transaction dated Friday, May 22nd. The stock was sold at an average price of $156.59, for a total value of $1,242,698.24. Following the sale, the chief financial officer directly owned 50,496 shares of the company’s stock, valued at approximately $7,907,168.64. This represents a 13.58% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.
Thomas Peter Kalmbach also recently made the following trade(s):
- On Tuesday, May 19th, Thomas Peter Kalmbach sold 11,903 shares of Globe Life stock. The shares were sold at an average price of $156.61, for a total value of $1,864,128.83.
- On Friday, May 8th, Thomas Peter Kalmbach sold 11,790 shares of Globe Life stock. The shares were sold at an average price of $152.02, for a total value of $1,792,315.80.
- On Monday, May 11th, Thomas Peter Kalmbach sold 15,637 shares of Globe Life stock. The shares were sold at an average price of $153.65, for a total value of $2,402,625.05.
Globe Life Stock Performance
Shares of GL stock opened at $154.39 on Thursday. The stock has a market cap of $11.99 billion, a PE ratio of 10.68 and a beta of 0.50. The business has a 50-day simple moving average of $148.25 and a 200-day simple moving average of $142.48. The company has a quick ratio of 0.07, a current ratio of 0.07 and a debt-to-equity ratio of 0.38. Globe Life Inc. has a 52-week low of $116.73 and a 52-week high of $157.92.
Globe Life Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Monday, July 6th will be paid a $0.33 dividend. This represents a $1.32 annualized dividend and a dividend yield of 0.9%. The ex-dividend date is Monday, July 6th. Globe Life’s payout ratio is currently 9.13%.
Analysts Set New Price Targets
Several equities analysts recently weighed in on GL shares. Keefe, Bruyette & Woods restated a “moderate buy” rating and issued a $168.00 price target on shares of Globe Life in a research note on Thursday, March 26th. Wells Fargo & Company boosted their price objective on Globe Life from $171.00 to $172.00 and gave the stock an “overweight” rating in a research note on Friday, April 10th. JPMorgan Chase & Co. boosted their price objective on Globe Life from $180.00 to $181.00 and gave the stock an “overweight” rating in a research note on Thursday, February 5th. Evercore set a $157.00 price objective on Globe Life in a research note on Wednesday, February 18th. Finally, Piper Sandler boosted their price objective on Globe Life from $167.00 to $175.00 and gave the stock an “overweight” rating in a research note on Tuesday. One research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and two have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $174.11.
View Our Latest Analysis on GL
Institutional Investors Weigh In On Globe Life
A number of large investors have recently made changes to their positions in GL. CYBER HORNET ETFs LLC purchased a new stake in shares of Globe Life in the second quarter valued at approximately $28,000. Hilton Head Capital Partners LLC purchased a new stake in shares of Globe Life in the fourth quarter valued at approximately $30,000. MUFG Securities EMEA plc purchased a new stake in shares of Globe Life in the second quarter valued at approximately $31,000. Torren Management LLC purchased a new stake in shares of Globe Life in the fourth quarter valued at approximately $37,000. Finally, Root Financial Partners LLC purchased a new stake in shares of Globe Life in the third quarter valued at approximately $44,000. 81.61% of the stock is currently owned by hedge funds and other institutional investors.
About Globe Life
Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.
The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.
Read More
- Five stocks we like better than Globe Life
- Abercrombie Rallies as Strong Q1 Earnings Extend Winning Streak
- TeraWulf Bets on Power Infrastructure to Lead AI Build-Out
- Amazon’s Alexa for Shopping Strengthens an Already Strong Bull Case
- Keysight: The AI and Defense Stock Seeing Big Price Target Boosts
Receive News & Ratings for Globe Life Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Globe Life and related companies with MarketBeat.com's FREE daily email newsletter.
